Fate Therapeutics (FATE)'s 30-day implied volatility (IV30) was 82.6% at the close on November 2, 2026, up from 72.4% the day before, against a 52-week range of 57.7% to 157.5%. Its 20-day historical volatility was 75.7%.
Data as of November 2, 2026.